US Patent Litigations are now available. Check here

EP2800567

TEVA BRANDED PHARMACEUTICAL PRODUCTS R & D
Application Number
EP12805442A
Filing Date
Dec 12, 2012
Status
Revoked
Jan 24, 2020
Grant Date
Sep 27, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2800567B1 was granted on Sep 27, 2017 by Teva Branded Pharmaceutical Products R & D The patent is currently Revoked.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionGB2264238
N/A
OppositionWO9413262
N/A
OppositionWO0193933
N/A
OppositionUS2004018153
N/A
OppositionWO2004054580
N/A
OppositionEP2201934
N/A
OppositionWO2011061498
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.